Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
December 11, 2019
 
24/7 Helpline: 800.272.3900
Opinions vary on Alzheimer's disease drug trial results
The pharmaceutical company Biogen has announced they are taking its data on the experimental drug aducanumab to the U.S. Food and Drug Administration (FDA) for review early next year. Alzheimer's Association Chief Science Officer Maria Carrillo, Ph.D., says, "This is an important moment for the Alzheimer's field." The Association looks forward to review of the data by the scientific community and the FDA.

Click here to read more
Man living with Alzheimer's wants doctors to understand importance of diagnosis
Keith Moreland was diagnosed with Alzheimer's disease in 2018 at age 57. A member of the Alzheimer's Association National Early-Stage Advisors Group, Moreland wants to help doctors understand the importance of disclosing an Alzheimer's diagnosis and direct other families to the best resources.
Click here to read more
Online Tools
Your Local Community
 
Help family and friends adjust to Alzheimer's
Part of living with Alzheimer's disease is adjusting to the experience and helping family and friends do the same. Knowing what to expect and what resources are available can make the process easier for you and those close to you.
Click here to read more
Your donations and support make a difference.
More Resources: 
Stages of Alzheimer's  | 
Behaviors  | 
Coping Strategies  | 
Care Training
My Preferences:
Unsubscribe
To stop receiving our weekly e-newsletter, simply unsubscribe.
 
Subscribe
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

 Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2019 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.